Brittany A Davidson
Assistant Professor of Obstetrics and Gynecology
Current Research Interests
My research interests revolve around 'the patient experience of cancer,' including patient preferences for genetic testing and management options in ovarian cancer, palliative care involvement in GYN cancers, communication strategies, post-operative pain management and medication compliance.
Current Appointments & Affiliations
- Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2017
Contact Information
- 25172 Morris Building, Box 3079 Duke Medical Center, Durham, NC 27710
- Box 3079 Duke Medical Center, Durham, NC 27710
-
brittany.davidson@duke.edu
(919) 684-0188
- Background
-
Education, Training, & Certifications
- Gynecologic Oncology Subspeciality Certification, American Board of Obstetrics and Gynecology 2019 - 2020
- Obstetrics and Gynecology Certification, American Board of Obstetrics and Gynecology 2016 - 2020
- Duke University 2013 - 2016
- University of Texas Southwestern Medical Center, Medical School 2009 - 2013
- M.D., University of Virginia 2009
-
Medical Licensure
- 2013-00137. North Carolina. 2013
-
Duke Appointment History
- Assistant Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2016 - 2020
- Clinical Associate in the Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2016
-
Leadership & Clinical Positions at Duke
-
Associate Program Director, Department of OB/GYN
Director of OB/GYN simulation
Director of Student and Trainee Education for GYN Oncology
-
Associate Program Director, Department of OB/GYN
- Recognition
-
Awards & Honors
- AAMC LEAD Scholar. American Association of Medical Colleges. 2020
- Caregiver of the Week. Duke OB/GYN Department . February 2019
- Duke LEADER participant. Duke University Office of Faculty Development. 2019
- Palliative Care Advocacy Award. Duke Palliative Care Division. 2019
- Excellence in Teaching National Award. APGO-CREOG . 2018
- Health Education Certificate Program. DukeAhead. 2018
- Junior Associate. VitalTalk. 2018
- Surgical Education Scholar. APGO-CREOG. 2018
- Fellow Teacher of the Year. Department of OB/GYN. 2016
- Expertise
-
Subject Headings
- Research
-
Selected Grants
-
Fellowships, Supported Research, & Other Grants
- Development and validation of a predictive model for emergency room utilization and unanticipated hospital admission in patients receiving treatment for ovarian cancer awarded by Charles B. Hammond OB/GYN Research Award 2018
- A quantitative and qualitative analysis of adherence to oral anti-cancer therapeutics in the gynecology oncology population awarded by Charles B. Hammond Research Fund 2018
- Qualitative assessment for end of life treatment options in women with high-risk platinum-resistant ovarian cancer awarded by Duke Cancer Control & Population Sciences 2017
- Understanding and predicting opioid use following gynecologic surgery awarded by Duke University Hammond grant 2017
-
External Relationships
- Tesaro
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Russo, Sandra, Joan L. Walker, Jay W. Carlson, Jeanne Carter, Leigh C. Ward, Allan Covens, Edward J. Tanner, et al. “Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.” Gynecol Oncol 160, no. 2 (February 2021): 625–32. https://doi.org/10.1016/j.ygyno.2020.10.026.Full Text Link to Item
-
Watson, Catherine H., Laura J. Fish, Margaret Falkovic, Karen Monuszko, Amelia Lorenzo, Laura J. Havrilesky, Angeles Alvarez Secord, and Brittany A. Davidson. “Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population.” Obstet Gynecol 136, no. 6 (December 2020): 1145–53. https://doi.org/10.1097/AOG.0000000000004170.Full Text Link to Item
-
Vetter, M. H., S. Smrz, P. A. Gehrig, K. Peng, K. Matsuo, B. A. Davidson, M. P. Cisa, et al. “Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?” Gynecol Oncol 159, no. 2 (November 2020): 354–58. https://doi.org/10.1016/j.ygyno.2020.08.004.Full Text Link to Item
-
Watson, Catherine H., Lindsay Soo, Brittany A. Davidson, Laura J. Havrilesky, Paula S. Lee, Leah J. McNally, Rebecca A. Previs, Angeles Alvarez Secord, Andrew Berchuck, and Noah D. Kauff. “Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 30, no. 10 (October 2020): 1583–88. https://doi.org/10.1136/ijgc-2020-001536.Full Text
-
Chung, Esther H., Tracy Truong, Karen R. Jooste, Jonathan E. Fischer, and Brittany A. Davidson. “The Implementation of Communication Didactics for OB/GYN Residents on the Disclosure of Adverse Perioperative Events.” J Surg Educ, September 25, 2020. https://doi.org/10.1016/j.jsurg.2020.09.001.Full Text Link to Item
-
Howell, E. P., J. Fischer, F. A. Valea, and B. A. Davidson. “Communication Matters: a Survey Study of Communication Didactics in Obstetrics/Gynecology Residency.” Medical Science Educator 30, no. 3 (September 1, 2020): 1069–76. https://doi.org/10.1007/s40670-020-01017-9.Full Text
-
Buckingham, Lindsey, Matthew Janssen, Emily M. Ray, Katherine Tucker, Brittany A. Davidson, Joshua Arenth, Carolyn Lefkowits, Joshua A. Jones, Paola Gehrig, and Christopher A. Jones. “Top Ten Tips Palliative Care Clinicians Should Know About Caring for Serious Illness in Pregnancy.” J Palliat Med 23, no. 5 (May 2020): 712–18. https://doi.org/10.1089/jpm.2019.0651.Full Text Link to Item
-
Uppal, Shitanshu, Paola A. Gehrig, Katherine Peng, Kristin L. Bixel, Koji Matsuo, Monica H. Vetter, Brittany A. Davidson, et al. “Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study.” J Clin Oncol 38, no. 10 (April 1, 2020): 1030–40. https://doi.org/10.1200/JCO.19.03012.Full Text Link to Item
-
Bixel, K., M. Vetter, B. Davidson, A. Berchuck, D. Cohn, L. Copeland, J. M. Fowler, et al. “Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.” Gynecol Oncol 156, no. 3 (March 2020): 530–34. https://doi.org/10.1016/j.ygyno.2019.12.016.Full Text Link to Item
-
VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.Full Text Open Access Copy Link to Item
-
Havrilesky, Laura J., Jui-Chen Yang, Paula S. Lee, Angeles Alvarez Secord, Jessie A. Ehrisman, Brittany Davidson, Andrew Berchuck, Kathleen M. Darcy, G Larry Maxwell, and Shelby D. Reed. “Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.” Cancer 125, no. 24 (December 15, 2019): 4399–4406. https://doi.org/10.1002/cncr.32447.Full Text Link to Item
-
Havrilesky, L. J., J. C. Yang, P. S. Lee, A. A. Secord, J. A. Ehrisman, B. Davidson, A. Berchuck, K. M. Darcy, G. L. Maxwell, and S. D. Reed. “Patient Preferences for Attributes of Primary Surgical Debulking Versus Neoadjuvant Chemotherapy for Treatment of Newly Diagnosed Ovarian Cancer.” Obstetrical and Gynecological Survey 74, no. 12 (December 1, 2019): 718–19. https://doi.org/10.1097/OGX.0000000000000743.Full Text
-
Gillen, J., K. A. Mills, J. Dvorak, B. Zheng, T. Thai, R. Salani, C. M. Cosgrove, B. Davidson, P. H. Thaker, and K. N. Moore. “Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab.” Gynecologic Oncology Reports 30 (November 1, 2019). https://doi.org/10.1016/j.gore.2019.100502.Full Text
-
Puechl, Allison M., Fumiko Chino, Laura J. Havrilesky, Brittany A. Davidson, and Junzo P. Chino. “Place of death by region and urbanization among gynecologic cancer patients: 2006-2016.” Gynecol Oncol 155, no. 1 (October 2019): 98–104. https://doi.org/10.1016/j.ygyno.2019.07.013.Full Text Link to Item
-
Lim, Stephanie L., Allison M. Puechl, Gloria Broadwater, Jessie A. Ehrisman, Amelia Lorenzo, Jonathan Foote, Brittany A. Davidson, Junzo Chino, and Laura J. Havrilesky. “Gender variation in Medicare utilization and payments in gynecologic oncology.” Gynecol Oncol 154, no. 3 (September 2019): 602–7. https://doi.org/10.1016/j.ygyno.2019.06.007.Full Text Link to Item
-
Gaillard, Stéphanie L., Kaitlyn J. Andreano, Laurie M. Gay, Meghan Steiner, Matthew S. Jorgensen, Brittany Anne Davidson, Laura J. Havrilesky, et al. “Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies.” Gynecol Oncol 154, no. 1 (July 2019): 199–206. https://doi.org/10.1016/j.ygyno.2019.04.010.Full Text Link to Item
-
Secord, Angeles Alvarez, Michael McCollum, Brittany A. Davidson, Gloria Broadwater, Robert Squatrito, Laura J. Havrilesky, Anne C. Gabel, et al. “Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.” Gynecologic Oncology 153, no. 3 (June 2019): 555–61. https://doi.org/10.1016/j.ygyno.2019.03.246.Full Text
-
Veade, Ashley E., Jonathan Foote, Jessie Ehrisman, Gloria Broadwater, Brittany A. Davidson, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, and Laura J. Havrilesky. “Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.” World J Surg Oncol 17, no. 1 (May 10, 2019): 80. https://doi.org/10.1186/s12957-019-1620-x.Full Text Link to Item
-
Watson, Catherine H., Micael Lopez-Acevedo, Gloria Broadwater, Amy H. Kim, Jessie Ehrisman, Brittany A. Davidson, Paula S. Lee, Fidel Valea, Andrew Berchuck, and Laura J. Havrilesky. “A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.” Gynecol Oncol 153, no. 2 (May 2019): 399–404. https://doi.org/10.1016/j.ygyno.2019.02.021.Full Text Link to Item
-
Berger, Miles, Deborah Oyeyemi, Mobolaji O. Olurinde, Heather E. Whitson, Kent J. Weinhold, Marty G. Woldorff, Lewis A. Lipsitz, et al. “The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.” J Am Geriatr Soc 67, no. 4 (April 2019): 794–98. https://doi.org/10.1111/jgs.15770.Full Text Open Access Copy Link to Item
-
Davidson, Brittany A., Gloria Broadwater, Aleia Crim, Robert Boccacio, Kristin Bixel, Floor Backes, Rebecca A. Previs, et al. “Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.” Gynecol Oncol 152, no. 3 (March 2019): 554–59. https://doi.org/10.1016/j.ygyno.2018.12.011.Full Text Link to Item
-
Davidson, Brittany A., Jessie Ehrisman, Shelby D. Reed, Jui-Chen Yang, Adam Buchanan, and Laura J. Havrilesky. “Preferences of women with epithelial ovarian cancer for aspects of genetic testing.” Gynecol Oncol Res Pract 6 (2019): 1. https://doi.org/10.1186/s40661-019-0066-8.Full Text Link to Item
-
Lim, Stephanie L., Haley A. Moss, Angeles Alvarez Secord, Paula S. Lee, Laura J. Havrilesky, and Brittany A. Davidson. “Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis.” Gynecol Oncol 151, no. 3 (December 2018): 506–12. https://doi.org/10.1016/j.ygyno.2018.09.020.Full Text Link to Item
-
Salinaro, Julia R., Allison M. Puechl, Laura J. Havrilesky, and Brittany A. Davidson. “Gender trends in gynecologic oncology authorship: Implications for the critical evaluation of gender distribution in academic rank and leadership positions.” Gynecol Oncol 151, no. 3 (December 2018): 542–46. https://doi.org/10.1016/j.ygyno.2018.10.009.Full Text Link to Item
-
Davidson, Brittany A., Haley A. Moss, Jaclyn Arquiette, and Arif H. Kamal. “Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Endometrial Cancer.” J Palliat Med 21, no. 6 (June 2018): 857–61. https://doi.org/10.1089/jpm.2018.0053.Full Text Link to Item
-
Davidson, Brittany A., Jessie Ehrisman, Sara Abbott, Zach Harmon, Angeles A. Secord, Andrew Berchuck, Paula S. Lee, et al. “Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer.” Int J Gynecol Pathol 37, no. 3 (May 2018): 252–55. https://doi.org/10.1097/PGP.0000000000000418.Full Text Link to Item
-
Davidson, Brittany A., Haley A. Moss, and Arif H. Kamal. “Top 10 Tips Palliative Care Clinicians Should Know When Caring for Patients with Ovarian Cancer.” J Palliat Med 21, no. 2 (February 2018): 250–54. https://doi.org/10.1089/jpm.2017.0679.Full Text Link to Item
-
Makker, Vicky, Angela K. Green, Robert M. Wenham, David Mutch, Brittany Davidson, and David Scott Miller. “New therapies for advanced, recurrent, and metastatic endometrial cancers.” Gynecologic Oncology Research and Practice 4, no. 1 (December 2017). https://doi.org/10.1186/s40661-017-0056-7.Full Text
-
Phippen, N. T., A. A. Secord, S. Wolf, G. Samsa, B. Davidson, A. P. Abernethy, D. Cella, et al. “Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.” Gynecol Oncol 147, no. 1 (October 2017): 98–103. https://doi.org/10.1016/j.ygyno.2017.07.121.Full Text Link to Item
-
Madden-Fuentes, Ramiro Jose, Bridget F. Koontz, Michael R. Harrison, Daniel J. George, Brittany Davidson, Brian F. Gilmore, Judd W. Moul, Christopher Mantyh, and Andrew C. Peterson. “How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?” Oncology (Williston Park) 31, no. 4 (April 15, 2017): 286–94.Link to Item
-
Foote, Jonathan R., Stephanie Gaillard, Gloria Broadwater, Julie A. Sosa, Brittany Davidson, Mohamed A. Adam, Angeles Alvarez Secord, Monica B. Jones, Junzo Chino, and Laura J. Havrilesky. “Disparities in the surgical staging of high-grade endometrial cancer in the United States.” Gynecol Oncol Res Pract 4 (2017): 1. https://doi.org/10.1186/s40661-016-0036-3.Full Text Open Access Copy Link to Item
-
Davidson, Brittany A., Jonathan Foote, Leslie H. Clark, Gloria Broadwater, Jessie Ehrisman, Paola Gehrig, Whitney Graybill, Angeles Alvarez Secord, and Laura J. Havrilesky. “Tumor grade and chemotherapy response in endometrioid endometrial cancer.” Gynecol Oncol Rep 17 (August 2016): 3–6. https://doi.org/10.1016/j.gore.2016.04.006.Full Text Link to Item
-
Davidson, Brittany A., Jonathan Foote, Stacey L. Brower, Chunqiao Tian, Laura J. Havrilesky, and Angeles Alvarez Secord. “Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis.” Gynecol Oncol Res Pract 3 (2016): 13. https://doi.org/10.1186/s40661-016-0032-7.Full Text Open Access Copy Link to Item
-
Myers, Evan R., Patricia Moorman, Jennifer M. Gierisch, Laura J. Havrilesky, Lars J. Grimm, Sujata Ghate, Brittany Davidson, et al. “Benefits and Harms of Breast Cancer Screening: A Systematic Review.” Jama 314, no. 15 (October 20, 2015): 1615–34. https://doi.org/10.1001/jama.2015.13183.Full Text Link to Item
-
Davidson, Brittany A., Christa I. Nagel, Debra L. Richardson, Siobhan M. Kehoe, David S. Miller, and Jayanthi S. Lea. “Outcomes of Treatment of Gestational Trophoblastic Neoplasia in a Primarily Indigent Urban Population.” J Reprod Med 60, no. 5–6 (May 2015): 243–48.Link to Item
-
Davidson, B. A., C. I. Nagel, D. L. Richardson, S. M. Kehoe, D. S. Miller, and J. S. Lea. “Outcomes of Treatment of Gestational Trophoblastic Neoplasia in a Primarily Indigent Urban Population.” Journal of Reproductive Medicine 60, no. 5–6 (2015): 243–48.
-
Davidson, Brittany Anne, and Patricia G. Moorman. “Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.” Expert Opinion on Drug Safety 13, no. 10 (October 2014): 1375–82. https://doi.org/10.1517/14740338.2014.951327.Full Text
-
Davidson, Brittany A., and Angeles Alvarez Secord. “Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer.” Int J Womens Health 6 (2014): 289–300. https://doi.org/10.2147/IJWH.S49781.Full Text Open Access Copy Link to Item
-
Davidson, Brittany Anne, Jennifer M. Rubatt, David L. Corcoran, Deanna K. Teoh, Marcus Q. Bernardini, Lisa A. Grace, William John Soper, et al. “Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.” Front Oncol 4 (2014): 163. https://doi.org/10.3389/fonc.2014.00163.Full Text Link to Item
-
-
Conference Papers
-
Gaillard, S., G. Broadwater, W. S. Andrews, M. D. Starr, R. A. Previs, L. J. Havrilesky, B. A. Davidson, et al. “Pembrolizumab window study: Illuminating the immunologic landscape in gynecologic cancers.” In Gynecologic Oncology, 159:41–41. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.06.087.Full Text
-
Howell, E. P., C. H. Watson, A. M. Puechl, and B. A. Davidson. “Gynecologic malignancy-associated bowel obstruction: Outcomes and prognostic implications.” In Gynecologic Oncology, 159:316–316. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.572.Full Text
-
Monuszko, K., I. V. Rodriguez, A. Lorenzo, L. J. Havrilesky, and B. A. Davidson. “The power of P: Preoperative patient pain perceptions predict inpatient pain medication requirements following gynecologic oncology surgery.” In Gynecologic Oncology, 159:301–301. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.536.Full Text
-
Puechl, A. M., S. Lim, L. A. Gatta, A. Lorenzo, A. N. Galanos, T. Truong, A. Berchuck, et al. “A systematic outpatient quality improvement intervention results in earlier goals of care conversations between high-risk gynecologic cancer patients and their providers.” In Gynecologic Oncology, 159:306–306. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.549.Full Text
-
Rodriguez, I. V., J. R. Salinaro, O. Kohrman, A. S. Habib, L. J. Havrilesky, J. E. Jelovsek, and B. A. Davidson. “Development of a prediction model for postoperative opioid use following gynecologic surgery.” In Gynecologic Oncology, 159:274–75. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.479.Full Text
-
Watson, C. H., L. Fish, L. J. Havrilesky, A. A. Secord, and B. A. Davidson. “The gynecologic oncology patient experience with oral anti-cancer therapy: A quantitative and qualitative analysis of medication adherence.” In Gynecologic Oncology, 159:285–285. Elsevier BV, 2020. https://doi.org/10.1016/j.ygyno.2020.05.499.Full Text
-
Ryan, Emma, Julia Salinaro, Laura J. Havrilesky, and Brittany Anne Davidson. “Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy: A cost-effectiveness analysis.” In Journal of Clinical Oncology, Vol. 38, 2020.Link to Item
-
Davidson, Brittany, Laura Fish, Laura S. Porter, J Kelly Davis, and Laura Havrilesky. “HIGH RISK PLATINUM OVARIAN CANCER PATIENTS AND THEIR CAREGIVERS: IDENTIFYING NEEDS NEAR THE END OF LIFE.” In Annals of Behavioral Medicine, 54:S688–S688, 2020.Link to Item
-
Hoerger, Michael, Brittany Davidson, Claire C. Conley, J Nicholas Dionne-Odom, and Maija Reblin. “ACCELERATING PALLIATIVE CARE SCIENCE: IDENTIFYING THE CHALLENGES OF PATIENTS, CAREGIVERS, & CLINICIANS VIA MIXED METHODS.” In Annals of Behavioral Medicine, 54:S688–S688, 2020.Link to Item
-
Moss, H. A., C. Watson, B. A. Davidson, K. C. Nolte, T. Truong, J. M. Weber, and L. J. Havrilesky. “To admit or not admit: An evaluation of avoidable and potentially avoidable admissions on a gynecologic oncology service.” In Gynecologic Oncology, 154:284–284. Elsevier BV, 2019. https://doi.org/10.1016/j.ygyno.2019.04.668.Full Text
-
Salinaro, J. R., R. B. Boccaccio, J. A. Ehrisman, L. J. Havrilesky, A. A. Secord, K. N. Moore, and B. A. Davidson. “Rate of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer.” In Gynecologic Oncology, 154:29–30. Elsevier BV, 2019. https://doi.org/10.1016/j.ygyno.2019.04.071.Full Text
-
Secord, A. A., R. A. Previs, B. Pothuri, K. C. Strickland, L. Gay, D. A. Levine, B. A. Davidson, and J. A. Elvin. “Molecular driven endometrial cancer therapy (MODEL): A prospective paradigm using molecular tumor profiling to direct therapy in women with advanced/recurrent endometrial cancer.” In Gynecologic Oncology, 154:248–248. Elsevier BV, 2019. https://doi.org/10.1016/j.ygyno.2019.04.572.Full Text
-
Uppal, Shitanshu, Paola Gehrig, Monica Hagan Vetter, Brittany Anne Davidson, Brittany F. Lees, Laurie Leigh Brunette, Katherine Tucker, et al. “Recurrence rates in cervical cancer patients treated with abdominal versus minimally invasive radical hysterectomy: A multi-institutional analysis of 700 cases.” In Journal of Clinical Oncology, 37:5504–5504. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5504.Full Text
-
Watson, Catherine H., Allison Puechl, Truong Tracy, Stephanie Lim, Laura Jean Havrilesky, and Brittany Anne Davidson. “Therapy discontinuation processes in a gynecologic oncology population.” In Journal of Clinical Oncology, Vol. 37. AMER SOC CLINICAL ONCOLOGY, 2019.Link to Item
-
Watson, Catherine H., Brittany Anne Davidson, Laura Jean Havrilesky, Paula S. Lee, Leah McNally, Haley Moss, Rebecca A. Previs, et al. “Management of high, moderate, and low penetrance ovarian cancer susceptibility gene mutations: An assessment of current practice patterns.” In Journal of Clinical Oncology, 37:1536–1536. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.1536.Full Text
-
Puechl, Allison, Stephanie Lim, Tracy Truong, Laura Havrilesky, and Brittany Anne Davidson. “The feasibility of an inpatient intervention to improve end-of-life care in gynecologic oncology patients.” In Journal of Clinical Oncology, 36:69–69. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.34_suppl.69.Full Text
-
Davidson, B. A., J. Ehrisman, S. D. Reed, J. Yang, F. R. Johnson, A. H. Buchanan, P. K. Marcom, and L. J. Havrilesky. “PMD180 - THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE: A DISCRETE CHOICE EXPERIMENT.” In Value in Health, 21:S274–S274. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.09.1629.Full Text
-
Secord, A Alvarez, M. McCollum, B. Davidson, G. Broadwater, R. Squatrito, L. Havrilesky, A. Gabel, A. Nixon, and L. Duska. “PHASE II TRIAL OF NINTEDANIB IN PATIENTS WITH BEVACIZUMAB-RESISTANT RECURRENT EPITHELIAL OVARIAN, TUBAL, AND PERITONEAL CANCER.” In International Journal of Gynecological Cancer, 28:457–457. BMJ PUBLISHING GROUP, 2018.Link to Item
-
Davidson, Brittany Anne, Jonathan Foote, Jessie Ehrisman, Jui-Chen Yang, Shelby D. Reed, Reed Johnson, Paula S. Lee, Angeles Alvarez Secord, Andrew Berchuck, and Laura Jean Havrilesky. “What factors drive the choice of a genetic test? A prospective study of the preferences of women with ovarian cancer.” In Journal of Clinical Oncology, 36:e13621–e13621. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e13621.Full Text
-
Gaillard, Stephanie, Laurie M. Gay, Meghan Steiner, Kaitlyn Andreano, Brittany Anne Davidson, Laura Jean Havrilesky, Angeles Alvarez Secord, et al. “Assessment of activating estrogen receptor 1 (ESR1) mutations in gynecologic malignancies.” In Journal of Clinical Oncology, 36:5590–5590. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5590.Full Text
-
Lim, Stephanie, Allison Puechl, Gloria Broadwater, Jessie Ehrisman, Amelia Lorenzo, Jonathan Foote, Brittany Anne Davidson, Junzo P. Chino, and Laura Jean Havrilesky. “Variability in Medicare utilization and payment among gynecologic oncologists.” In Journal of Clinical Oncology, 36:5599–5599. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5599.Full Text
-
Salinaro, Julia, Jessie Ehrisman, Angeles Alvarez Secord, and Brittany Anne Davidson. “Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced ovarian cancer.” In Journal of Clinical Oncology, 36:e17531–e17531. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e17531.Full Text
-
Gillen, J., K. A. Mills, J. Dvorak, B. Zheng, T. Thai, R. Salani, C. M. Cosgrove, B. Davidson, P. H. Thaker, and K. N. Moore. “Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab.” In Gynecologic Oncology, 147:198–99. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.07.031.Full Text
-
Davidson, Brittany Anne, Robert Squatrito, Linda R. Duska, Laura Jean Havrilesky, Nyssa Schwager, Michael McCollum, Sanja Arapovic, and Angeles Alvarez Secord. “Phase II evaluation of nintedanib in the treatment of bevacizumab-resistant persistent/recurrent ovarian, fallopian tube, or primary peritoneal carcinoma.” In Journal of Clinical Oncology, 34:TPS5601–TPS5601. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.tps5601.Full Text
-
Davidson, B. A., D. B. Mannschreck, G. Broadwater, M. Lopez-Acevedo, P. S. Lee, L. J. Havrilesky, F. A. Valea, A. Berchuck, and A. A. Secord. “Findings at laparoscopy, not debulking status, are associated with survival in advanced stage ovarian cancer after neoadjuvant chemotherapy.” In Gynecologic Oncology, 137:111–111. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.276.Full Text
-
Roque, Dario R., Stuart Pierce, Kemi Morenikeji Doll, Brittany Davidson, Amanda Lynn Jackson, Emily Meichun Ko, Dominic T. Moore, et al. “Endometrial cancer outcomes in hypertensive women treated with beta-blocker.” In Journal of Clinical Oncology, 32:e16545–e16545. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e16545.Full Text
-
-
- Teaching & Mentoring
-
Recent Courses
-
Advising & Mentoring
-
Mentoring 1st year fellow in research projects
Continuity clinic mentor for 3rd year medical students
Mentoring residents in their 3rd year research project requirement
-
Mentoring 1st year fellow in research projects
-
Teaching Activities
-
Courses Taught:
2020-present 4th Year Capstone: Facilitator
2019-present Cultural Determinants of Healthcare Disparities: Facilitator
2018-present OB/GYN 404C Prep for OB/GYN Residency: Instructor
-Breaking Bad News
-Physician Wellness
Medical Student Case Based Learning: Instructor
GYN Laparoscopic Training Curriculum: Instructor
Director of GYN Oncology Resident Education
OB/GYN Resident Coaching Program: Program Co-lead and Coach
-
Courses Taught:
- Scholarly, Clinical, & Service Activities
-
Presentations & Appearances
- Accelerating palliative care science: Identifying the challenges of patients, caregivers, & clinicians via mixed methods. . National Meeting. Society of Behavioral Medicine. 2020 - 2020 2020
- PRIMARY SURGICAL DEBULKING OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING: A PATIENT PREFERENCE STUDY. May 2019 2019
- Association between isolated tumor cells and recurrence in stage I endometrial cancer. Society of Gynecologic Oncology Annual Meeting. March 2019 2019
- Rates of venous thromboembolism in women with ovarian cancer undergoing me-adjuvant chemotherapy. Society of Gynecologic Oncology Annual Meeting. March 2019 2019
- Inviting Fellows to Join the Band: Strategies for Integrating Fellows into Medical Student & Resident Education. APGO/CREOG Annual Meeting. February 2019 2019
- Therapy discontinuation processes in a gynecologic oncology population. . American Society of Clinical Oncology. 2019 - 2019 2019
- THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE: A DISCRETE CHOICE EXPERIMENT. ISPOR Europe. November 2018 2018
- The feasibility of an inpatient intervention to improve end-of-life care in high risk Gynecologic Oncology patients. Palliative & Supportive Care in Oncology Symposium . November 2018 2018
-
Service to the Profession
- Member. Education Committee, Society of Gynecologic Oncology. 2020 2020
- Journal Reviewer. Obstetrics & Gynecology. 2019 2019
- Reviewer. Progress In Palliative Care Journal. 2018 2018
- Junior Associate. Vital Talk. 2017 2017
- Reviewer. Journal of Oncology Practice. 2017 2017
- Member. SGO Wellness Taskforce. 2013 2013
-
Academic & Administrative Activities
-
Duke Office for Institutional Equity Curriculum Development Steering Committee
Duke Cancer Institute Sexual Health Working Group
Duke Cancer Institute Quality Improvement Committee
Duke OB/GYN Wellness Committee
Duke OB/GYN Core Curriculum Committee
-
Duke Office for Institutional Equity Curriculum Development Steering Committee
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.
